Stocklytics Platform

Income Statement

publish
The Stocklytics Income Statement Screener empowers investors to focus on companies with strong financial fundamentals. Whether you’re interested in growth, profitability, or overall revenue strength, this tool helps you make informed decisions.
name
arrow_downwardRevenue Price $ Change % Change Revenue Growth % Gross Profit Operating Income Net Income EBITDA EPS Diluted
Asset logo for symbol ELEV
ELEVElevation Oncology
_$0.31$0.00arrow_drop_up0.21%-_-$45.44M-$45.70M-$41.97M-0.80
Asset logo for symbol IONM
IONMAssure Holdings
_$0.13-$0.03arrow_drop_down21.21%-_-$20.08M-$26.07M$0.00-369.70
Asset logo for symbol SMFL
SMFLSmart for Life
_$0.08$0.040.00%-$3.09M-$11.31M-$22.67M-$9.03M-362.17
Asset logo for symbol RIBT
RIBTRiceBran Technologies
_$0.09$0.000.00%-_-$6.35M-$8.55M-$5.26M-1.19
Asset logo for symbol PPTA
PPTAPerpetua Resources
_$13.82$0.58arrow_drop_up4.43%-_$40.27K-$18.77M-$46.96M-0.22
Asset logo for symbol DDS
DDSDillard's
_$416.28-$6.95arrow_drop_down1.64%-$6.48B$4.75B$593.50M$999.14M36.81
BIMI
BIMIBimi International Medical
_$0.01-$0.01arrow_drop_down50.00%arrow_drop_up6.78%$5.09M-$3.81M-$10.51M-$6.83M-6.39
Asset logo for symbol TCON
TCONTracon Pharmaceuticals
_$0.12-$0.01arrow_drop_down9.72%arrow_drop_up33.83%$12.03M-$6.89M-$3.58M$6.12M5.93
Asset logo for symbol CCS
CCSCentury Communities
_$52.98$0.87arrow_drop_up1.67%arrow_drop_up19.12%$1.02B$512.66M$333.81M$479.34M10.40
MGRD
MGRDMGRD
_$14.94-$0.04arrow_drop_down0.26%-$1.12B$1.05B$740.60M$0.000.00
Asset logo for symbol KALV
KALVKalVista Pharmaceuticals
_$11.40-$0.01arrow_drop_down0.13%-_-$140.44M-$126.64M-$170.75M-3.68
Asset logo for symbol SFIX
SFIXStitch Fix
_$4.18-$0.09arrow_drop_down2.21%-$592.03M-$118.88M-$118.88M-$28.44M-0.82
Asset logo for symbol SABSW
SABSWSAB Biotherapeutics
_$0.03$0.00arrow_drop_up38.58%-_-$38.07M-$42.19M-$46.91M0.29
Asset logo for symbol DENN
DENNDenny's
_$3.80$0.01arrow_drop_up0.39%-$332.10M$45.31M$21.57M$70.67M0.41
Asset logo for symbol ARBK
ARBKArgo Blockchain plc American Depositary Shares
_$0.42-$0.02arrow_drop_down5.40%arrow_drop_up54.04%$4.85M-$24.51M-$35.03M$5.33M-0.90
Asset logo for symbol ASPS
ASPSAltisource Portfolio Solutions SA
_$0.83$0.01arrow_drop_up1.20%-$29.65M-$16.76M-$56.29M$6.14M-1.35
Asset logo for symbol VTLE
VTLEVital Energy
_$15.15$0.13arrow_drop_up0.88%arrow_drop_up26.15%$1.82B-$22.55M-$173.52M$1.19B-4.74
Asset logo for symbol VIRX
VIRXViracta Therapeutics
_$0.07-$0.08arrow_drop_down53.86%-_-$50.69M-$51.05M-$46.77M-1.10
Asset logo for symbol DNUT
DNUTKrispy Kreme
_$2.92-$0.02arrow_drop_down0.84%-$1.25B-$8.73M$3.81M$122.97M0.02
Asset logo for symbol UHS
UHSUniversal Health Services
_$185.74-$0.50arrow_drop_down0.26%arrow_drop_up10.82%$15.82B$1.68B$1.16B$2.26B16.82
Showing 3921-3940 of 4978
Results per page:

Gain deeper insights into a company's earnings with the Stocklytics Income Statement Screener, designed to rank stocks in descending order of revenue. This tool allows you to quickly assess companies with the highest revenue and their overall income performance, providing key financial metrics for smarter investment decisions. Our screener offers detailed insights into the following income statement components: - Revenue Growth – Identify companies with impressive year-over-year growth, a critical indicator of potential future success. - Gross Profit – Analyze how well a company is managing its core production costs to generate profit. - Operating Income – Understand a company’s ability to generate profit from its primary operations, excluding non-operational activities. - Net Income – Examine the company's bottom line after all expenses, providing a clear picture of profitability. - EBITDA – Evaluate a company’s earnings before interest, taxes, depreciation, and amortization to get a sense of its overall profitability and operating performance. - EPS Diluted – Review earnings per share on a diluted basis, reflecting potential impacts of convertible securities and giving you a clearer picture of shareholder returns. By using the Stocklytics Income Statement Screener, you’ll have access to vital financial data that will help you evaluate a company's performance, profitability, and growth potential. Why the Income Statement Matters: - Revenue Performance: Understand which companies are excelling at generating top-line revenue. - Profitability: Analyze margins and earnings to identify financially strong companies. - Earnings Per Share: Evaluate companies with high earnings per share, a key metric for investors.
toolkit image

Discover the Power of Stocklytics Tools

Our suite of tools empowers you to make informed decisions, seize opportunities, and stay ahead in the competitive trading world.

See Stocklytics Tools

Take Your Investments to a Whole New Level